Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Peginterferon alfa-2b |
| Trade Name | Sylatron |
| Synonyms | PEG-IFN |
| Drug Descriptions |
Sylatron (peginterferon alfa-2b) is polyethylene glycol (PEG)-conjugated recombinant interferon alpha, subtype 2b, which may have antitumor activity (PMID: 23002124, PMID: 16953837, PMID: 24741445). |
| DrugClasses | |
| CAS Registry Number | 215647-85-1 |
| NCIT ID | C1845 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bria-OTS + Cyclophosphamide + Peginterferon alfa-2b + Tislelizumab | Bria-OTS Cyclophosphamide Peginterferon alfa-2b Tislelizumab | 0 | 1 |
| Interferon gamma + Peginterferon alfa-2b | Interferon gamma Peginterferon alfa-2b | 0 | 1 |
| Peginterferon alfa-2b | Peginterferon alfa-2b | 0 | 4 |
| Peginterferon alfa-2b + Pembrolizumab | Peginterferon alfa-2b Pembrolizumab | 0 | 2 |